• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Helius Medical Technologies Inc (NQ: HSDT )

    0.5450 +0.0050 (+0.93%)
    Streaming Delayed Price Updated: 12:38 PM EDT, Oct 21, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Helius Medical Technologies Inc

    < Previous 1 2 3 Next >
    Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results
    Company to host call at 4:30pm today 
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies, Inc. to Release Second Quarter 2024 Financial Results on August 12, 2024
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    MicroCap Rodeo’s Spring into Summer Conference, June 6th 2024 - 25 Presenting Companies
    Via ACCESSWIRE
    Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference
    Via ACCESSWIRE
    Helius Medical Technologies, Inc. Announces Third-Party Reimbursement for PoNS® from Major Insurance Carrier
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MS
    Company Will Highlight Major Milestones on Accessibility and Reimbursement Fronts 
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results
    Company to host call at 4:30pm today 
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies, Inc. Announces Preliminary CMS Payment Determination of Reimbursement for Portable Neuromodulation Stimulator (PoNS®)
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies Inc. (NASDAQ: HSDT) Making Surprising Moves in Wednesday Session
    Via Investor Brand Network
    Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies Inc. (NASDAQ: HSDT) is One of Tuesday Morning’s Most Active Stocks
    Via Investor Brand Network
    Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Booth and Special Event at APTA Combined Sections Meeting Will Highlight Physical Therapists’ Ability to Customize PoNS Therapy® to Improve Gait in People with MS
    Event Appearance Caps Year of Growth: PoNS®-Trained PTs Now Found Across the United States 
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies to Present at NobleCon19 Annual Conference
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies, Inc. Reports Third Quarter 2023 Financial Results
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    Helius Medical Technologies, Inc. Announces Study Results Demonstrating That PoNS Therapy™ Helps Patients with Traumatic Brain Injury Return to Work
    From Helius Medical Technologies, Inc.
    Via GlobeNewswire
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.